Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice
- 31 May 2004
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 187 (1) , 137-149
- https://doi.org/10.1016/j.expneurol.2004.01.003
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitorsArthritis & Rheumatism, 2002
- Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cellsHepatology, 2002
- Proteases Acting on Mutant Huntingtin Generate Cleaved Products that Differentially Build Up Cytoplasmic and Nuclear InclusionsPublished by Elsevier ,2002
- Remotivation Therapy and Huntingtonʼs DiseaseJournal of Neuroscience Nursing, 2001
- Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: Implications for Huntington’s disease pathologyProceedings of the National Academy of Sciences, 1999
- Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in BrainScience, 1997
- More hippocampal neurons in adult mice living in an enriched environmentNature, 1997
- Polar zippers: Their role in human diseaseProtein Science, 1994
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993
- Molecular Structure and Expression of the Gene Locus on Chromosome 21 Encoding the Cu/Zn Superoxide Dismutase and Its Relevance to Down SyndromeAnnals of the New York Academy of Sciences, 1985